Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clinical prediction models for anthracycline-associated cardiotoxicity among pediatric cancer survivors--ready for prime time?

Pediatric blood & cancer - 1 Aug 2013

Ojha Rohit P, Gurney James G, Green Daniel M

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anthracyclines
Share to Antineoplastic Agents
Share to Cardiovascular Diseases
Share to Glucuronosyltransferase

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Membrane Transport Proteins

Share to Models, Biological

Share to Polymorphism, Single Nucleotide

Source

Identifiers

PMID: 23630170
DOI: 10.1002/pbc.24548

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clinical prediction models for anthracycline-associated cardiotoxicity among pediatric cancer survivors--ready for prime time?PMID 23630170Read ↗

Genetic factors in anthracycline-induced cardiotoxicity in patients treated for pediatric cancer.Semantic proximity Read ↗

Prognostic Factors for Cardiotoxicity Among Children With Cancer: Definition, Causes and Diagnosis With Omics TechnologiesSemantic proximity Read ↗

Genetic Susceptibility and Mechanisms Underlying the Pathogenesis of Anthracycline-Associated Cardiotoxicity.Semantic proximity Read ↗

Current views on anthracycline cardiotoxicity.Semantic proximity Read ↗

Pediatric Anthracycline‐Induced Cardiotoxicity: Mechanisms, Pharmacogenomics, and Pluripotent Stem‐Cell ModelingSemantic proximity Read ↗

Predicting the 10-year risk of cardiomyopathy in long-term survivors of childhood cancer: a report from the St. Jude Lifetime Cohort and the Childhood Cancer Survivor StudySemantic proximity Read ↗

Pharmacogenomic prediction of anthracycline-induced cardiotoxicity in children.Semantic proximity Read ↗

Recommendations for genetic testing to reduce the incidence of anthracycline-induced cardiotoxicity.Semantic proximity Read ↗

Exome array analysis identifies GPR35 as a novel susceptibility gene for anthracycline-induced cardiotoxicity in childhood cancer.Semantic proximity Read ↗

The genetic underpinnings of anthracycline-induced cardiomyopathy predisposition.Semantic proximity Read ↗

Influence of genetic biomarkers on cardiac diseases in childhood cancer survivors: a systematic review.Semantic proximity Read ↗

Possible roles of genetic variations in chemotherapy related cardiotoxicity in pediatric acute lymphoblastic leukemia and osteosarcoma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.